Clinical Trials on Pharyngeal Neoplasms

Total 108613 results

National Cancer Centre, Singapore
Terry Fox Foundation

Completed

18F-FMISO PET Guided Dose Escalation in Nasopharyngeal Carcinoma - a Feasibility and Planning Study

Nasopharyngeal Carcinoma

Singapore
Sun Yat-sen University

Active, not recruiting

Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma.

Nasopharyngeal Carcinoma

China
Novartis Pharmaceuticals

Completed

Safety and Efficacy Study of PDR001 in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

United States, China, Taiwan, Singapore, Hong Kong, Thailand, France
The University of Hong Kong

Completed

A Prospective Study of Molecular Detection of Salvageable Early Recurrent Nasopharyngeal Carcinoma After Radiotherapy

Nasopharyngeal Carcinoma
Sun Yat-sen University
First People's Hospital of Foshan; Affiliated Cancer Hospital & Institute of... and other collaborators

Unknown

Endostar for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

Nasopharyngeal Carcinoma

China
Fujian Cancer Hospital
China Immunotech (Beijing) Biotechnology Co., Ltd.

Unknown

EBV-TCR-T（YT-E001）for Patients With EBV-positive Recurrent or Metastatic NPC

Nasopharyngeal Carcinoma

China
National Cancer Institute (NCI)

Completed

Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s)

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Unknown

Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Shanghai Proton and Heavy Ion Center

Terminated

Trail Evaluating Carbon Ion Radiotherapy for Locally Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guangxi Medical University
Second Affiliated Hospital of Guangxi Medical University; Guilin Medical University... and other collaborators

Unknown

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Nasopharyngeal Cancer | Nasopharynx Cancer
Groupe Oncologie Radiotherapie Tete et Cou

Terminated

Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers (NPC2006)

Nasopharyngeal Cancers

France, Tunisia, Morocco, Romania
Kuwait Cancer Control Center

Unknown

EBV Positive Nasopharyngeal Carcinoma Treated With Concurrent Chemo-radiotherapy With or Without Anti-Viral Drug

Drug Use for Unapproved Schedule

Kuwait
Guilin Medical University, China
Wuzhou Red Cross Hospital; Guangxi Naxishan Hospital; National Hospital of Guangxi...

Unknown

Maintenance Treatment of Apatinib in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.
Sun Yat-sen University

Completed

Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma (FMTN-I-LNPC)

Locally Advanced Nasopharyngeal Carcinoma

China
Taichung Veterans General Hospital

Completed

Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA

Nasopharyngeal Carcinoma | EBV Related Carcinoma
Zhejiang Cancer Hospital

Unknown

Apatinib in Treating Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma

China
Hunan Province Tumor Hospital

Unknown

Polymorphisms in Key Genes of Glycolytic Pathway: Influence on Radiosensitivity in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Radiosensitivity | Single Nucleotide Polymorphisms

China
Ministry of Health, Malaysia

Unknown

Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma (FOSCAN)

Nasopharyngeal Carcinoma

Malaysia
Sanofi

Completed

Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Hong Kong
National Taiwan University Hospital

Unknown

Treatment Result of KTP Laser Nasopharyngectomy in Recurrent NPC Patients

Nasopharyngeal Carcinoma | Recurrent

Taiwan
Affiliated Hospital of Nantong University

Not yet recruiting

Pretreatment With HCQ Before Radiotherapy and Chemotherapy in Advanced NPC Patients

Nasopharyngeal Carcinoma

China
Jiangxi Provincial Cancer Hospital

Recruiting

Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma | Maintenance Therapy | High-Risk Cancer

China
Sun Yat-sen University
First People's Hospital of Foshan; Sichuan Cancer Hospital and Research Institute and other collaborators

Recruiting

Individualized Elective Neck Irradiation in NPC Patients

Nasopharyngeal Carcinoma

China
Fudan University

Recruiting

Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Gemcitabine and Camrelizumab Plus Apatinib Versus Cisplatin in First-line Treatment of RM-NPC

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Patients With Stage III-IVa Nasopharyngeal Carcinoma With or Without a Mobile Medical Platform Full-course Nutritional Intervention

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

Metastatic Nasopharyngeal Cancer

China
Sun Yat-sen University

Recruiting

Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Not yet recruiting

Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
First Affiliated Hospital, Sun Yat-Sen University
Sun Yat-sen University

Recruiting

To Develop and Validate a Nasoendoscopic Intelligent Diagnostic System for Nasopharyngeal Carcinoma

Artificial Intelligence | Otolaryngological Disease

China
Sun Yat-sen University

Not yet recruiting

A Phase II Clinical Study of Treprilimab in the Treatment of Recurrent Nasopharyngeal Carcinoma After Re-irradiation

Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Zhejiang Provincial People's Hospital; The Central Hospital of Lishui City; First... and other collaborators

Recruiting

Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma (IRCNPC)

Locally Advanced Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Affiliated Hospital of Nantong University

Active, not recruiting

Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients

Nasopharyngeal Carcinoma

China
BioSyngen Pte Ltd

Completed

A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal Carcinoma

EBV-positive Nasopharyngeal Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Completed

SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Active, not recruiting

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

Nasopharyngeal Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Completed

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

China
Postgraduate Institute of Medical Education and...
Indian Council of Medical Research

Unknown

Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx (EARN)

Carcinoma, Nasopharyngeal

India
Kiang Wu Hospital

Completed

PD-L1 and BRAF Expression in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Chang Gung Memorial Hospital

Completed

Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma
Gruppo Oncologico del Nord-Ovest
Mario Negri Institute for Pharmacological Research

Unknown

Denosumab In Ebv Nasopharyngeal Carcinoma As A Model For RankMediated Immunologic Modulation Of Virus-Related Tumours (Dern)

Nasopharyngeal Carcinoma | EBV Related Carcinoma

Italy
Sun Yat-sen University

Unknown

Phase I Trial of LMP2 Antigen-specific TCR T-cell Therapy for Recurrent and Metastatic NPC Patients

Nasopharyngeal Carcinoma

China
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Wei Jiang
Wuzhou Red Cross Hospital; Laibin People's Hospital; Guangxi Naxishan Hospital; People's Hospital of Baise and other collaborators

Unknown

Adjuvant Treatment of Apatinib in Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Hong Kong Nasopharyngeal Cancer Study Group Limited
Sanofi; The University of Hong Kong; Merck Sharp & Dohme LLC; Roche Pharma AG

Completed

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)

Nasopharyngeal Carcinoma

China

Clinical Trials on Pharyngeal Neoplasms

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations